Heidelberg Pharma AG (HPHA.DE)
EUR 2.38
(-0.42%)
EUR 2.38
(-0.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.85 Million | 18.51 Million | 1.74 Million | 8.48 Million | 7.3 Million | 3.66 Million |
| Cost of Revenue | 3.25 Million | 4.67 Million | 4.71 Million | 5.59 Million | 3.73 Million | 2.2 Million |
| Gross Profit | 6.6 Million | 13.83 Million | -2.96 Million | 2.88 Million | 3.57 Million | 1.45 Million |
| Operating Expenses | 27.81 Million | 32.16 Million | 22.83 Million | 21.45 Million | 13.93 Million | 13.51 Million |
| Selling, General and Administrative Expenses | 5.24 Million | 4.81 Million | 3.98 Million | 3.58 Million | 3.14 Million | 2.96 Million |
| Research and Development Expenses | 28.07 Million | 26.37 Million | 18.75 Million | 18.28 Million | 10.94 Million | 10.67 Million |
| Other Expenses | -5.5 Million | 976.58 Thousand | 94.21 Thousand | -416.35 Thousand | -152.44 Thousand | 323 Thousand |
| Cost and Expenses | 31.06 Million | 36.84 Million | 27.54 Million | 27.05 Million | 17.67 Million | 15.72 Million |
| Operating Income | -21.2 Million | -18.33 Million | -25.63 Million | -18.56 Million | -10.36 Million | -11.67 Million |
| Interest Expense | 761.6 Thousand | 840 Thousand | 494.49 Thousand | 13.56 Thousand | - | - |
| Income Tax Expense | - | 1.91 Million | 494.49 Thousand | 4564.00 | 5006.00 | 570.45 Thousand |
| Earnings before Tax | -20.34 Million | -17.78 Million | -26.13 Million | -18.36 Million | -10.14 Million | -11.67 Million |
| Net Income | -20.34 Million | -19.7 Million | -26.63 Million | -18.37 Million | -10.14 Million | -11.67 Million |
| Earnings Per Share Basic | -0.44 | -0.53 | -0.82 | -0.61 | -0.36 | -0.41 |
| Earnings Per Share Diluted | -0.44 | -0.53 | -0.82 | -0.61 | -0.36 | -0.41 |
| Weighted Average Shares Outstanding | 46.59 Million | 37.23 Million | 32.5 Million | 29.89 Million | 28.2 Million | 28.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 46.59 Million | 37.23 Million | 32.5 Million | 29.89 Million | 28.2 Million | 28.2 Million |
| Gross Margin | 0.67 | 0.75 | -1.69 | 0.34 | 0.49 | 0.40 |
| EBIT Margin | -1.90 | -0.88 | -14.20 | -2.08 | -1.34 | -3.08 |
| Profit Margin | -2.06 | -1.06 | -15.22 | -2.16 | -1.39 | -3.18 |
| EBITDA | -18.7 Million | -16.18 Million | -24.82 Million | -17.55 Million | -9.59 Million | -11.71 Million |
| Earnings Before Tax Margin | -2.15 | -0.99 | -14.65 | -2.19 | -1.42 | -3.18 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.19 Million | 2.78 Million | 1.26 Million | 9.85 Million | 3.22 Million | 2.24 Million |
| Cost of Revenue | 141.36 Thousand | 1.54 Million | 247.17 Thousand | 4.13 Million | 383.12 Thousand | 125.05 Thousand |
| Gross Profit | 1.05 Million | 1.24 Million | 1.01 Million | 5.72 Million | 2.84 Million | 2.11 Million |
| Operating Expenses | 7.15 Million | 7.03 Million | 6.09 Million | 33.24 Million | 7.41 Million | 9.15 Million |
| Selling, General and Administrative Expenses | 1.75 Million | 1.52 Million | 1.01 Million | - | 1.4 Million | 1.33 Million |
| Research and Development Expenses | 5.06 Million | 5.51 Million | 5.07 Million | - | 6 Million | 7.29 Million |
| Other Expenses | 336.69 Thousand | 1.63 Million | 592.38 Thousand | 634 Thousand | -6.33 Million | 6.98 Million |
| Cost and Expenses | 7.29 Million | 8.57 Million | 6.33 Million | 37.37 Million | 7.79 Million | 9.28 Million |
| Operating Income | -5.96 Million | -5.78 Million | -5.07 Million | -27.51 Million | -4.57 Million | -55.51 Thousand |
| Interest Expense | 1548.00 | 37.26 Thousand | 101.58 Thousand | 761.6 Thousand | 96.25 Thousand | 159.68 Thousand |
| Income Tax Expense | 372.35 Thousand | -48.93 Thousand | 48.93 Thousand | 1.00 | -277.42 Thousand | 99.99 Thousand |
| Earnings before Tax | -5.59 Million | -4.22 Million | -4.44 Million | -20.34 Million | -4.78 Million | 213.1 Thousand |
| Net Income | -5.59 Million | -4.17 Million | -4.49 Million | -20.34 Million | -4.5 Million | 113.11 Thousand |
| Earnings Per Share Basic | -0.12 | -0.09 | -0.10 | - | -0.10 | 0.00 |
| Earnings Per Share Diluted | -0.12 | -0.09 | -0.10 | - | -0.10 | 0.00 |
| Weighted Average Shares Outstanding | 45.07 Million | 46.6 Million | 46.6 Million | 46.59 Million | 46.6 Million | 46.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.07 Million | 46.6 Million | 46.6 Million | 46.59 Million | 46.6 Million | 46.56 Million |
| Gross Margin | 0.88 | 0.45 | 0.80 | 0.58 | 0.88 | 0.94 |
| EBIT Margin | -4.51 | -2.00 | -3.83 | - | -1.35 | 0.26 |
| Profit Margin | -4.69 | -1.50 | -3.55 | -2.06 | -1.40 | 0.05 |
| EBITDA | -5.37 Million | -5.57 Million | -4.85 Million | - | -4.35 Million | 592.45 Thousand |
| Earnings Before Tax Margin | -5.00 | -2.08 | -4.00 | -2.79 | -1.42 | -0.02 |
0238
2000
002125
QUIS
1063
ARTO